CLINICAL_TRIALS
research
· 2026-04-20
Clinical Trial Update: Pembrolizumab in High-risk Thyroid Cancer [Phase 2]
Summary
Phase 2 clinical trial update for pembrolizumab in high-risk differentiated thyroid cancer; study is currently recruiting.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Istituti Clinici Scientifici Maugeri SpA | Conditions: Differentiated Thyroid Cancer | Phase 2 | Status: RECRUITING